BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9332885)

  • 1. Effect of lamotrigine on carbamazepine epoxide/carbamazepine serum concentration ratios in adult patients with epilepsy.
    Gidal BE; Rutecki P; Shaw R; Maly MM; Collins DM; Pitterle ME
    Epilepsy Res; 1997 Oct; 28(3):207-11. PubMed ID: 9332885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No increase in carbamazepine-10,11-epoxide during addition of lamotrigine treatment in children.
    Eriksson AS; Boreus LO
    Ther Drug Monit; 1997 Oct; 19(5):499-501. PubMed ID: 9357090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction?
    Besag FM; Berry DJ; Pool F; Newbery JE; Subel B
    Epilepsia; 1998 Feb; 39(2):183-7. PubMed ID: 9577998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral contraceptives on lamotrigine levels depends on comedication.
    Wegner I; Wilhelm AJ; Lambrechts DA; Sander JW; Lindhout D
    Acta Neurol Scand; 2014 Jun; 129(6):393-8. PubMed ID: 24571554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose pharmacokinetics of carbamazepine-10,11-epoxide in patients on lamotrigine monotherapy.
    Pisani F; Xiao B; Fazio A; Spina E; Perucca E; Tomson T
    Epilepsy Res; 1994 Dec; 19(3):245-8. PubMed ID: 7698101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
    Svinarov DA; Pippenger CE
    Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.
    Reunanen M; Dam M; Yuen AW
    Epilepsy Res; 1996 Mar; 23(2):149-55. PubMed ID: 8964276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamazepine and carbamazepine-10,11-epoxide clearance measurements during continuous venovenous hemofiltration in a massive overdose.
    Smollin CG; Petrie MS; Kearney T
    Clin Toxicol (Phila); 2016 Jun; 54(5):424-7. PubMed ID: 26942940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group.
    Brodie MJ; Overstall PW; Giorgi L
    Epilepsy Res; 1999 Oct; 37(1):81-7. PubMed ID: 10515178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine-induced carbamazepine toxicity: an interaction with carbamazepine-10,11-epoxide.
    Warner T; Patsalos PN; Prevett M; Elyas AA; Duncan JS
    Epilepsy Res; 1992 Apr; 11(2):147-50. PubMed ID: 1618180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the drug interaction between carbamazepine and lamotrigine in the treatment of refractory epilepsy patients].
    Pereira LR; Velasco TR; Ceiki-Sakamoto A; de Carvalho D
    Rev Neurol; 2006 Jul 16-31; 43(2):74-7. PubMed ID: 16838253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental and therapeutic pharmacology of antiepileptic drugs.
    Miura H
    Epilepsia; 2000; 41 Suppl 9():2-6. PubMed ID: 11156504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine.
    Rowan AJ; Ramsay RE; Collins JF; Pryor F; Boardman KD; Uthman BM; Spitz M; Frederick T; Towne A; Carter GS; Marks W; Felicetta J; Tomyanovich ML;
    Neurology; 2005 Jun; 64(11):1868-73. PubMed ID: 15955935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoin.
    Anderson GD; Gidal BE; Messenheimer JA; Gilliam FG
    Epilepsy Res; 2002 May; 49(3):211-7. PubMed ID: 12076842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of short-term lamotrigine treatment on pharmacokinetics of carbamazepine.
    Malminiemi K; Keränen T; Kerttula T; Moilanen E; Ylitalo P
    Int J Clin Pharmacol Ther; 2000 Nov; 38(11):540-5. PubMed ID: 11097146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
    Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
    Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid loss of efficacy to the antiseizure drugs lamotrigine and carbamazepine: a novel experimental model of pharmacoresistant epilepsy.
    Srivastava AK; Alex AB; Wilcox KS; White HS
    Epilepsia; 2013 Jul; 54(7):1186-94. PubMed ID: 23750799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly.
    Saetre E; Perucca E; Isojärvi J; Gjerstad L;
    Epilepsia; 2007 Jul; 48(7):1292-302. PubMed ID: 17561956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents.
    Steinborn B
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():9-15. PubMed ID: 16119616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study.
    Wegner I; Wilhelm AJ; Sander JW; Lindhout D
    Epilepsy Behav; 2013 Oct; 29(1):217-21. PubMed ID: 23995050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.